Fig. 7
From: Efficacy and mechanism of Shenqi Compound in inhibiting diabetic vascular calcification
SQC activation of Hippo-YAP pathway. A The GO enrichment analysis between SQC and model group. B The KEGG enrichment analysis between SQC and model group. C Representative IF staining (scale bar, 200 μm) (n = 4). D The relative mRNA level of YAP, CTGF and CYR61. Model group compared with control group: #P ≤ 0.05, ##P ≤ 0.01. SQC group compared with model group: *P ≤ 0.05, **P ≤ 0.01